The Next Era of Medical Devices and Diagnostics Innovation

Medical devices and diagnostics are entering a pivotal new era as health systems confront workforce shortages, rising chronic disease burdens, and cost pressures. Innovation priorities are shifting from hospital-centric, reactive care toward distributed, preventive, and personalized models. What was once a collection of specialized tools and fragmented systems is rapidly transforming into a connected, intelligence-driven ecosystem — one that integrates data, precision, and patient experience to redefine healthcare delivery.  

The question is no longer whether to adopt new technologies, but how to scale them responsibly and align them with measurable impact. Success hinges on identifying not only emerging technologies, which are currently driving industry growth and will continue to drive growth, but also the new pathways through which AI-enabled imaging, noninvasive diagnostics, point-of-care connectivity, and automation can create tangible clinical and operational value. 

Lux’s analysis shows that precision health technologies, accessibility, and regulatory agility now lead as the strongest growth drivers, while traditional silos between medical devices, life sciences, and healthcare delivery continue to dissolve. The next wave of progress will depend on integrating sensing, analytics, automation, and therapeutic delivery into unified platforms that elevate both performance and patient outcomes. 

In this webinar, Lux will present its latest research on innovation in medical devices and diagnostics, highlighting how emerging technologies centered on personalization and decentralization are transforming industry strategies. You’ll gain insights into the themes that will define innovation success in 2026 and beyond and learn where your organization must lead, not follow.